Author | Year | Country/region | Ethnicity | Design | Diagnosis | Case | Control | HWE | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
VV | VW | WW | VV | VW | WW | |||||||
Rs679620 | Â | Â | Â | Â | Â | AA | AG | GG | AA | AG | GG | Â |
Briški N | 2020 | Croatia | Caucasian | Case–control | ATEN | 16 | 30 | 17 | 9 | 51 | 32 | 0.08 |
El Khoury L (I) | 2016 | UK | Caucasian | Case–control | ATEN | 31 | 46 | 16 | 35 | 71 | 25 | 0.31 |
El Khoury L (II) | 2016 | UK | Caucasian | Case–control | ARUP | 6 | 8 | 11 | 35 | 71 | 25 | 0.31 |
Figueiredo EA | 2020 | Brazil | Mixed | Case–control | RCT | 41 | 111 | 58 | 90 | 275 | 200 | 0.78 |
Gibbon A (I) | 2017 | Australia | Caucasian | Case–control | ATEN | 20 | 40 | 17 | 39 | 94 | 58 | 0.94 |
Haug KBF | 2018 | Norway | Caucasian | Cohort | PTEN | 5 | 21 | 7 | 22 | 53 | 18 | 0.18 |
Lulinska-Kuklik E | 2019 | Poland | Caucasian | Case–control | ACLI | 54 | 107 | 68 | 59 | 93 | 40 | 0.77 |
Nie G | 2019 | China | Asian | Case–control | ATEN | 78 | 460 | 546 | 234 | 950 | 1004 | 0.68 |
Posthumus M | 2012 | South Africa | Caucasian | Case–control | ACLI | 53 | 94 | 34 | 57 | 99 | 59 | 0.25 |
Raleigh SM (I) | 2009 | South Africa | Caucasian | Case–control | ATEN | 15 | 32 | 28 | 24 | 55 | 19 | 0.22 |
Raleigh SM (II) | 2009 | South Africa | Caucasian | Case–control | ARUP | 8 | 20 | 10 | 24 | 55 | 19 | 0.22 |
Rs591058 | Â | Â | Â | Â | Â | TT | TC | CC | TT | TC | CC | Â |
Briški N | 2020 | Croatia | Caucasian | Case–control | ATEN | 10 | 25 | 13 | 9 | 51 | 32 | 0.08 |
Gibbon A (I) | 2017 | Australia | Caucasian | Case–control | ATEN | 20 | 39 | 18 | 38 | 93 | 60 | 0.86 |
Gibbon A (III) | 2017 | South Africa | Caucasian | Case–control | ACLI | 80 | 182 | 64 | 59 | 106 | 60 | 0.39 |
Haug KBF | 2018 | Norway | Caucasian | Cohort | PTEN | 5 | 21 | 7 | 22 | 51 | 20 | 0.35 |
Lulinska-Kuklik E | 2019 | Poland | Caucasian | Case–control | ACLI | 54 | 107 | 68 | 59 | 93 | 40 | 0.77 |
Raleigh SM (I) | 2009 | South Africa | Caucasian | Case–control | ATEN | 15 | 32 | 26 | 25 | 53 | 19 | 0.34 |
Raleigh SM (II) | 2009 | South Africa | Caucasian | Case–control | ARUP | 9 | 20 | 10 | 25 | 53 | 19 | 0.34 |
Rs650108 | Â | Â | Â | Â | Â | GG | GA | AA | GG | GA | AA | Â |
Briški N | 2020 | Croatia | Caucasian | Case–control | ATEN | 35 | 23 | 5 | 31 | 50 | 11 | 0.18 |
Gibbon A (I) | 2017 | Australia | Caucasian | Case–control | ATEN | 34 | 27 | 6 | 90 | 56 | 13 | 0.32 |
Gibbon A (III) | 2017 | South Africa | Caucasian | Case–control | ACLI | 205 | 99 | 15 | 122 | 90 | 12 | 0.38 |
Haug KBF | 2018 | Norway | Caucasian | Cohort | PTEN | 19 | 13 | 1 | 54 | 35 | 4 | 0.58 |
Raleigh SM (I) | 2009 | South Africa | Caucasian | Case–control | ATEN | 39 | 28 | 7 | 51 | 42 | 2 | 0.05 |
Raleigh SM (II) | 2009 | South Africa | Caucasian | Case–control | ARUP | 20 | 16 | 2 | 51 | 42 | 2 | 0.05 |
Rs3025058 | Â | Â | Â | Â | Â | 5A5A | 5A6A | 6A6A | 5A5A | 5A6A | 6A6A | Â |
Assunção JH | 2017 | Brazil | Mixed | Case–control | RCT | 15 | 38 | 11 | 4 | 44 | 16 | 0.01 |
Gibbon A (I) | 2017 | Australia | Caucasian | Case–control | ATEN | 20 | 40 | 17 | 40 | 93 | 57 | 0.86 |
Gibbon A (II) | 2017 | South Africa | Caucasian | Case–control | ATEN | 12 | 30 | 27 | 24 | 51 | 18 | 0.33 |
Gibbon A (III) | 2017 | South Africa | Caucasian | Case–control | ACLI | 77 | 185 | 64 | 57 | 108 | 60 | 0.55 |
Godoy-Santos AL | 2017 | Brazil | Mixed | Case–control | TTEN | 15 | 34 | 19 | 12 | 61 | 27 | 0.02 |
Malila S | 2011 | Thailand | Asian | Case–control | ACLI | 1 | 22 | 63 | 1 | 20 | 79 | 0.84 |
Miao K | 2019 | China | Asian | Case–control | RCT | 6 | 48 | 96 | 8 | 42 | 100 | 0.21 |